Comparative Efficacy of Different Doses of Mesenchymal Stem Cells Derived from Different Tissue Sources for Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Knee osteoarthritis (KOA) remains a leading cause of disability, and mesenchymal stem cells (MSCs) show potential for KOA treatment. However, existing studies demonstrate conflicting results on the optimal dose and tissue source of MSCs for KOA treatment. This gap limits evidence-based treatment decisions.
Source: PubMed Central
